A week of celebration and inspiration — Boston-style
At Solve, MIT will host gathering of leaders to spur action on world problems.
Finding 911 callers instantly
Mobile app automatically sends a caller’s location and medical data to dispatch centers.
Personalized heart models for surgical planning
System can convert MRI scans into 3D-printed, physical models in a few hours.
Turbocharging medical translation
Jeff Karp’s diverse multidisciplinary team brings novel solutions to a wide array of health challenges.
Could a pen change how we diagnose brain function?
Team from MIT's Computer Science and Artificial Intelligence Lab detects dementia using AI and a digital pen.
Study: Firms “underinvest” in long-term cancer research
Tweaks to the R&D pipeline could create new drugs and greater social benefit.
New material opens possibilities for super-long-acting pills
A pH-responsive polymer gel could create swallowable devices, including capsules for ultra-long drug delivery.
How do you hack health care?
With MIT Hacking Medicine, brilliant minds converge at MIT to contribute to design thinking for health care.
3 Questions: Carlo Ratti on big data and health predictions
MIT researcher discusses a new study on correlations among medical problems.
Uncovering the mechanism of our oldest anesthetic
MIT researchers reveal brainwave changes in patients receiving nitrous oxide, or “laughing gas.”
Major step for implantable drug-delivery device
MIT spinout signs deal to commercialize microchips that release therapeutics inside the body.
D-Lab and Tata Center team wins $100K Vodafone award for mobile stethoscope
Rich Fletcher and Daniel Chamberlain will use their winnings to field-test a low-cost mobile device to diagnose pulmonary disease in rural India.
Making cancer treatment more accessible
MIT collaborates on a smaller, lighter delivery system for proton-beam radiotherapy.
Neural engineering for middle schoolers
MIT STEM Mentoring Program introduces students from Boston, Cambridge, and Lawrence to an evolving field.
3 Questions: Kenneth Oye on regulating drugs
New potential for “homemade” opiates raises oversight issues.